NEVPF
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Jan 23 closing price
Capitalization
45.13M
Intraday BUY SELL Signals
TERN
Price
$27.12
Change
-$0.44 (-1.60%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
2.44B
131 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NEVPF vs TERN

Header iconNEVPF vs TERN Comparison
Open Charts NEVPF vs TERNBanner chart's image
Abliva AB
Price$0.03
Change-$0.00 (-0.00%)
Volume$58.9K
Capitalization45.13M
Terns Pharmaceuticals
Price$27.12
Change-$0.44 (-1.60%)
Volume$87.07K
Capitalization2.44B
NEVPF vs TERN Comparison Chart in %
NEVPF
Daily Signal:
Gain/Loss:
TERN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NEVPF vs. TERN commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEVPF is a Hold and TERN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (NEVPF: $0.03 vs. TERN: $27.12)
Brand notoriety: NEVPF and TERN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NEVPF: 100% vs. TERN: 142%
Market capitalization -- NEVPF: $45.13M vs. TERN: $2.44B
NEVPF [@Biotechnology] is valued at $45.13M. TERN’s [@Biotechnology] market capitalization is $2.44B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEVPF’s FA Score shows that 0 FA rating(s) are green whileTERN’s FA Score has 0 green FA rating(s).

  • NEVPF’s FA Score: 0 green, 5 red.
  • TERN’s FA Score: 0 green, 5 red.
According to our system of comparison, TERN is a better buy in the long-term than NEVPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEVPF’s TA Score shows that 1 TA indicator(s) are bullish while TERN’s TA Score has 5 bullish TA indicator(s).

  • NEVPF’s TA Score: 1 bullish, 0 bearish.
  • TERN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, TERN is a better buy in the short-term than NEVPF.

Price Growth

NEVPF (@Biotechnology) experienced а 0.00% price change this week, while TERN (@Biotechnology) price change was +33.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Reported Earning Dates

TERN is expected to report earnings on Mar 31, 2026.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TERN($2.44B) has a higher market cap than NEVPF($45.1M). TERN YTD gains are higher at: 389.531 vs. NEVPF (-22.222). NEVPF has higher annual earnings (EBITDA): -87.99M vs. TERN (-105M). TERN has more cash in the bank: 315M vs. NEVPF (32.7M). NEVPF (0) and TERN (0) have equivalent revenues.
NEVPFTERNNEVPF / TERN
Capitalization45.1M2.44B2%
EBITDA-87.99M-105M84%
Gain YTD-22.222389.531-6%
P/E RatioN/AN/A-
Revenue00-
Total Cash32.7M315M10%
Total DebtN/A1.13M-
FUNDAMENTALS RATINGS
NEVPF: Fundamental Ratings
NEVPF
OUTLOOK RATING
1..100
40
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
7

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NEVPFTERN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
13%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
13%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
NEVPF
Daily Signal:
Gain/Loss:
TERN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GEMRX16.88N/A
N/A
abrdn Emerging Markets R
JVLAX26.60N/A
N/A
JHancock Disciplined Value A
SGNFX51.79N/A
N/A
Sparrow Growth No-Load
FCGBX2.80N/A
N/A
Templeton Global Dynamic Income C
HFYYX13.48N/A
N/A
Hartford Schroders Intl Multi-Cp Val Y

NEVPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEVPF has been closely correlated with MLTX. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if NEVPF jumps, then MLTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEVPF
1D Price
Change %
NEVPF100%
N/A
MLTX - NEVPF
70%
Closely correlated
+1.12%
IMA - NEVPF
66%
Loosely correlated
-4.19%
ATYR - NEVPF
65%
Loosely correlated
-3.27%
CELC - NEVPF
61%
Loosely correlated
+2.87%
INBX - NEVPF
59%
Loosely correlated
+5.86%
More

TERN and

Correlation & Price change

A.I.dvisor indicates that over the last year, TERN has been loosely correlated with ELVN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if TERN jumps, then ELVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TERN
1D Price
Change %
TERN100%
-1.60%
ELVN - TERN
43%
Loosely correlated
-2.17%
SYRE - TERN
40%
Loosely correlated
+0.83%
MLTX - TERN
40%
Loosely correlated
+1.12%
NEVPF - TERN
40%
Loosely correlated
N/A
STOK - TERN
39%
Loosely correlated
-1.49%
More